Vitamin B12 helps in the manufacture of red blood cells
In general, insurance will not cover the drug unless it is prescribed for one of its FDA-approved indications
The concern is not that BPC-157 causes cancer
Weight loss injections, particularly glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), have become increasingly prescribed for obesity management in the UK
These effects are generally dose-dependent, mild to moderate in severity, and tend to improve over time
Tirzepatide, on the other hand, benefits from a growing body of real-world evidence and clinician familiarity, which could sustain its dominance even as next-generation agents emerge